TLR7 and COVID-19: Furthermore, male identified patients (which typically have low levels of estrogen and only one X chromosome encoding TLR7), are significantly more likely to be hospitalized and develop severe COVID-19 [154], and this could be partly a result of reduced IFN-I production by their pDCs.